158 related articles for article (PubMed ID: 35443723)
21. Effector Function Characteristics of Exhausted CD8+ T-cell in Microsatellite Stable and Unstable Gastric Cancer.
Han DS; Kwak Y; Lee S; Nam SK; Kong SH; Park DJ; Lee HJ; Kwon NJ; Lee HS; Yang HK
Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38637967
[TBL] [Abstract][Full Text] [Related]
22. Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer.
Wang CW; Muzakky H; Firdi NP; Liu TC; Lai PJ; Wang YC; Yu MH; Chao TK
NPJ Digit Med; 2024 May; 7(1):143. PubMed ID: 38811811
[TBL] [Abstract][Full Text] [Related]
23. Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors.
Han S; Xu Y; Chen D; Yang F; Wang M; Zhou Q; Wang G; Li L; Xu C; Wang W; Cai S; Xing N
iScience; 2024 Jan; 27(1):108290. PubMed ID: 38179060
[TBL] [Abstract][Full Text] [Related]
24. Combined cryoablation and PD-1 inhibitor synergistically enhance antitumor immune responses in Lewis lung adenocarcinoma mice via the PI3K/AKT/mTOR pathway.
Liu Q; Chen X; Qi M; Li Y; Chen W; Zhang C; Wang J; Han Z; Zhang C
Biochim Biophys Acta Mol Basis Dis; 2024 May; ():167262. PubMed ID: 38815768
[TBL] [Abstract][Full Text] [Related]
25. Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments.
Zhou C; Li M; Ren Y; Miao F; Wang Y; Wu T; Gou X; Li W
World J Surg Oncol; 2024 Jan; 22(1):25. PubMed ID: 38254190
[TBL] [Abstract][Full Text] [Related]
26. Controversies in upper GI oncology: MSI-H in gastroesophageal adenocarcinoma.
Petrillo A; Derks S; Smyth EC
ESMO Open; 2024 Feb; 9(2):102229. PubMed ID: 38244348
[No Abstract] [Full Text] [Related]
27. Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review.
Tang L; Xu H; Wu T; Wu W; Lu Y; Gu J; Wang X; Zhou M; Chen Q; Sun X; Cai H
Discov Oncol; 2024 Apr; 15(1):111. PubMed ID: 38602556
[TBL] [Abstract][Full Text] [Related]
28. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract][Full Text] [Related]
29. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.
Morgos DT; Stefani C; Miricescu D; Greabu M; Stanciu S; Nica S; Stanescu-Spinu II; Balan DG; Balcangiu-Stroescu AE; Coculescu EC; Georgescu DE; Nica RI
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339127
[TBL] [Abstract][Full Text] [Related]
30. Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy.
He J; Zhou Y; Sun L
Cell Commun Signal; 2024 Jan; 22(1):89. PubMed ID: 38297380
[TBL] [Abstract][Full Text] [Related]
31. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
Yang X; Lian B; Zhang N; Long J; Li Y; Xue J; Chen X; Wang Y; Wang Y; Xun Z; Piao M; Zhu C; Wang S; Sun H; Song Z; Lu L; Dong X; Wang A; Liu W; Pan J; Hou X; Guan M; Huo L; Shi J; Zhang H; Zhou J; Lu Z; Mao Y; Sang X; Wu L; Yang X; Wang K; Zhao H
BMC Med; 2024 Jan; 22(1):42. PubMed ID: 38281914
[TBL] [Abstract][Full Text] [Related]
32. MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathway.
Wang H; Min J; Ding Y; Yu Z; Zhou Y; Wang S; Gong A; Xu M
Biol Proced Online; 2024 Jan; 26(1):1. PubMed ID: 38178023
[TBL] [Abstract][Full Text] [Related]
33. Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma.
Zhou KI; Hanks BA; Strickler JH
J Gastrointest Cancer; 2023 Dec; ():. PubMed ID: 38133871
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms and biomarkers of immune-related adverse events in gastric cancer.
Ding P; Liu P; Meng L; Zhao Q
Eur J Med Res; 2023 Nov; 28(1):492. PubMed ID: 37936161
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 expression-related PI3K pathway correlates with immunotherapy efficacy in gastric cancer.
Liu L; Niu L; Zheng X; Xiao F; Sun H; Deng W; Cai J
Ther Adv Med Oncol; 2023; 15():17588359231205853. PubMed ID: 37868079
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients with a PD-L1 Positive Status: A Case Report.
Avgustinovich AV; Bakina OV; Afanas'ev SG; Spirina LV; Volkov AM
Curr Issues Mol Biol; 2023 Sep; 45(9):7642-7649. PubMed ID: 37754265
[TBL] [Abstract][Full Text] [Related]
37. Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction.
Shen X; Gong C; Liu M; Jiang Y; Xu Y; Ge Z; Tao Z; Dong N; Liao J; Yu L; Fang Q
PLoS One; 2023; 18(9):e0291754. PubMed ID: 37733793
[TBL] [Abstract][Full Text] [Related]
38. PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy.
Zheng Y; Wang Y; Lu Z; Wan J; Jiang L; Song D; Wei C; Gao C; Shi G; Zhou J; Fan J; Ke A; Zhou L; Cai J
Adv Sci (Weinh); 2023 Oct; 10(29):e2301928. PubMed ID: 37705495
[TBL] [Abstract][Full Text] [Related]
39. C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.
Liu X; Lv K; Wang J; Lin C; Liu H; Zhang H; Li H; Gu Y; Li R; He H; Xu J
Br J Cancer; 2023 Sep; 129(4):721-732. PubMed ID: 37422529
[TBL] [Abstract][Full Text] [Related]
40. Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit?
Liu Y; Hu P; Xu L; Zhang X; Li Z; Li Y; Qiu H
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
